Clinical Relevance and Management of "Pre-Interstitial Lung Disease".
Clinical Relevance and Management of "Pre-Interstitial Lung Disease".
复制标题
DOI:
10.1016/j.ccm.2021.03.009
复制
发表时间:
2021-06
影响因子:
5.7
通讯作者:
Putman RK
中科院分区:
文献类型:
--
作者:
Podolanczuk AJ;Putman RK
Cellular level changes that lead to interstitial lung disease (ILD) may take years to become clinically apparent and have been termed preclinical ILD Incidentally identified interstitial lung abnormalities (ILA) are increasingly being recognized on chest CTs done as part of lung cancer screening and for other purposes Many individuals found to have ILA will progress to clinically significant ILD ILA are independently associated with greater risk of death, lung function decline and incident lung cancer Current management recommendations focus on identifying individuals with ILA at high risk of progression, through a combination of clinical and radiological features Current consensus recommendations focus on active monitoring of individuals with ILA and high-risk features.
登录
查看更多内容
DOI:
10.1056/nejmoa1216076
发表时间:
2013-06-06
期刊:
The New England journal of medicine
影响因子:
--
作者:
Hunninghake GM;Hatabu H;Okajima Y;Gao W;Dupuis J;Latourelle JC;Nishino M;Araki T;Zazueta OE;Kurugol S;Ross JC;San José Estépar R;Murphy E;Steele MP;Loyd JE;Schwarz MI;Fingerlin TE;Rosas IO;Washko GR;O'Connor GT;Schwartz DA
通讯作者:
Schwartz DA
DOI:
10.1164/rccm.201406-1162oc
发表时间:
2015-02-15
影响因子:
24.7
作者:
Kropski, Jonathan A.;Pritchett, Jason M.;Blackwell, Timothy S.
通讯作者:
Blackwell, Timothy S.
DOI:
10.1164/rccm.201903-0511oc
发表时间:
2019-12-01
影响因子:
24.7
作者:
Hobbs, Brian D.;Putman, Rachel K.;Viviano, Lisa
通讯作者:
Viviano, Lisa
影响因子:
24.3
作者:
McGroder, Claire F.;Aaron, Carrie P.;Podolanczuk, Anna J.
通讯作者:
Podolanczuk, Anna J.
DOI:
10.1164/rccm.201701-0254oc
发表时间:
2017-11-15
影响因子:
24.7
作者:
Armstrong, Hilary F.;Podolanczuk, Anna J.;Lederer, David J.
通讯作者:
Lederer, David J.